Results 121 to 130 of about 32,465 (232)

Possible involvement of an endogenous opioid in the antihypertensive effect of clonidine in patients with essential hypertension.

open access: yes, 1982
The effect of naloxone on the hypotensive and bradycardiac action of clonidine was studied in 27 hospitalized patients with uncomplicated mild-to-moderate essential hypertension. In a double-blind, crossover study, clonidine, 0.3 mg/day orally for 3 days,
G Kunos, C Farsang, I Juhasz, J Kapocsi
core   +1 more source

Evaluation of the Effect of Oral Clonidine Premedication on PR- interval, in Rhinoplasty and Functional Endoscopic Sinus Surgery

open access: yesOtorhinolaryngology and Facial Plastic Surgery
Background: Clonidine, an alpha-2-agonist, attenuates the sympathetic response during general anesthesia and improves intra-operative hemodynamic stability. Clonidine has been associated with certain adverse cardiopulmonary effects.
Masoud Nashibi   +4 more
doaj   +1 more source

Reduced renovascular resistance by clonidine

open access: yes, 1979
The antihypertensive effect of clonidine has been attributed to acute inhibition of sympathetic outflow from the central nervous system. This conclusion is derived from experiments with single doses of clonidine.
Stone, Richard A   +3 more
core   +1 more source

[Clonidine in the treatment of cancer pain]

open access: yes, 2008
Clonidine is an alpha2-adrenergic agonist with analgetic properties. Due to its side-effects, the drug is administered via the epidural or spinal route.
Sjøgren, Per, Nielsen, Jonas Bøje
core   +1 more source

The Use of Intravenous Clonidine in Postoperative Pain Management: A Scoping Review. [PDF]

open access: yesActa Anaesthesiol Scand
Mohr T   +4 more
europepmc   +1 more source

Evaluating the Impact of Clonidine and Midazolam Premedication on Emergence Delirium in Pediatric Patients. [PDF]

open access: yesPaediatr Anaesth
Garioud ALB   +7 more
europepmc   +1 more source

Clonidin [PDF]

open access: yes, 2020
Helga Peter, Thomas Penzel
openaire   +1 more source

Home - About - Disclaimer - Privacy